Chemokines in Vascular Dysfunction and Remodeling
Open Access
- 1 November 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (11) , 1950-1959
- https://doi.org/10.1161/atvbaha.107.161224
Abstract
Vascular remodeling stands for structural changes of the vessel wall in response to various noxious stimuli, which results in reorganization of the vessel wall architecture. Luminal narrowing because of neointima formation and constrictive remodeling leading to hypoperfusion is the most relevant clinical effect. Smooth muscle cell (SMC) accumulation, inflammatory cell recruitment, and endothelial regeneration are the critical parts in obstructive vascular remodeling. Chemokines and chemokine receptors have a great impact on initiating and progressing neointimal formation by controlling each step of the remodeling process. SDF-1α regulates vascular repair by CXCR4-dependent smooth muscle progenitor cell recruitment, which contributes to the maladaptive response to injury. The three distinct chemokine-chemokine receptor pairs MCP-1/CCR2, RANTES/CCR5, and Fractalkine/CX3CR1 direct lesional leukocyte infiltration. In addition MCP-1/CCR2 and Fractalkine/CX3CR1 increase neointimal SMC expansion. In contrast, KC/Gro-α supports endothelial recovery through CXCR2, which attenuates neointima formation. These findings highlight the importance to characterize specific functions of the chemokine network to enable therapeutic intervention.Keywords
This publication has 112 references indexed in Scilit:
- Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2 −/− MiceCirculation, 2008
- Essential but differential role for CXCR4 and CXCR7 in the therapeutic homingof human renal progenitor cellsThe Journal of Experimental Medicine, 2008
- The A2b adenosine receptor protects against vascular injuryProceedings of the National Academy of Sciences, 2008
- Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7Proceedings of the National Academy of Sciences, 2007
- Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivoThe Journal of Experimental Medicine, 2006
- Tightening the BarrierArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Functional Characterization of SDF-1 Proximal PromoterJournal of Molecular Biology, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Essential Role of Monocyte Chemoattractant Protein-1 in Development of Restenotic Changes (Neointimal Hyperplasia and Constrictive Remodeling) After Balloon Angioplasty in Hypercholesterolemic RabbitsCirculation, 2002